FY2025 · ended Dec 31, 2025 · Revenue $8.27M, -5.4% YoY · Filed Mar 11, 2026
Nuwellis, Inc. (NUWE) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $8.3 million and a net loss of $17.5 million. Free cash flow was -$10.9 million. As of Jun 30, 2026 it held $3.9 million in cash and investments and $200,000 in total debt.
Revenue (TTM)
$9.01M
+8.4% vs year-ago TTM
Net income (TTM)
$-11.32M
+22.9% vs year-ago TTM
Operating cash flow (TTM)
$-12.46M
-44.8% vs year-ago TTM
Free cash flow (TTM)
$-12.59M
-46.1% vs year-ago TTM
EPS (TTM)
$-15.14
-100.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
2.31M
-47.2% vs prior year
Net cash
$3.72M
as of Jun 30, 2026
Operating margin
-142.9%
FY 2026
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NUWE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506492
- Former names
- CHF Solutions, Inc. (until Apr 16, 2021); Sunshine Heart, Inc. (until May 23, 2017)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $8.3M | $8.7M | $8.9M | $8.5M | $7.9M |
| Operating income | -$11.1M | -$11.0M | -$17.6M | -$17.2M | -$19.5M |
| Net income | -$17.5M | -$11.2M | -$20.2M | -$14.5M | -$19.6M |
| Diluted EPS | -$25.39 | -$353.30 | -$360.06 | -$83.55 | -$285.36 |
| Operating cash flow | -$10.8M | -$9.6M | -$17.9M | -$15.1M | -$17.8M |
| Free cash flow | -$10.9M | -$9.7M | -$18.1M | -$15.3M | -$18.1M |
| Total assets | $6.1M | $9.9M | $9.8M | $24.7M | $30.4M |
| Total liabilities | $3.5M | $3.3M | $6.6M | $12.3M | $4.5M |
| Stockholders' equity | $2.6M | $6.5M | $3.0M | $12.4M | $25.9M |
| Cash and investments | $1.1M | $5.1M | $3.8M | $18.3M | $8.7M |
| Total debt | $307,000 | $545,000 | $760,000 | $984,000 | $1.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 23, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 26, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 24, 2026 | Jul 24, 2026 |
All 1000 Nuwellis, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.